Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.
about
Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics ApproachPediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directionsLiver fibrosis markers of nonalcoholic steatohepatitis.A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains.Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histologyHepcidin in non-alcoholic fatty liver disease regulated by the TLR4/NF-κB signaling pathway.Comparisons of parallel potential biomarkers of 1H-MRS-measured hepatic lipid content in patients with non-alcoholic fatty liver disease.Role of Serum Biomarkers in Early Detection of Non-Alcoholic Steatohepatitis and Fibrosis in West Virginian Children.Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre studyTomato Juice Consumption Modifies the Urinary Peptide Profile in Sprague-Dawley Rats with Induced Hepatic Steatosis.Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists.Non-invasive assessment of liver fibrosis and prognosis.A simple scoring system using type IV collagen 7S and aspartate aminotransferase for diagnosing nonalcoholic steatohepatitis and related fibrosis.Screening for non-alcoholic fatty liver disease in children: do guidelines provide enough guidance?Late graft hepatitis and fibrosis in pediatric liver allograft recipients: Current concepts and future developments.Structure of proof of concept studies that precede a nonalcoholic steatohepatitis development program.Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease.Glycosylation site occupancy in health, congenital disorder of glycosylation and fatty liver disease.Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease.Sensitivity enhancement for detection of hyperpolarized 13 C MRI probes with 1 H spin coupling introduced by enzymatic transformation in vivo.Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease.Associations between Liver Enzyme Levels and Parameters of the Metabolic Syndrome in Obese Children.Vitamin D supplementation and non-alcoholic fatty liver disease: A critical and systematic review of clinical trials.Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease.Quantitative Assessment of Liver Steatosis and Affected Pathways with Molecular Imaging and Proteomic Profiling.Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis.Hepatoprotective Effects of Insect Extracts in an Animal Model of Nonalcoholic Fatty Liver Disease.Serum Interleukin-8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseCurrent status of imaging in nonalcoholic fatty liver disease
P2860
Q26753043-CC62CAD9-C844-4DA1-8C4E-C1D562EE6DC9Q28079432-5229E351-A756-4D21-9D69-1C8E2E3035BBQ30407625-8B09FED4-56F6-421D-BAE3-2E6B2FA3B9ABQ31171499-75031533-D573-46DA-844B-9FF8B1229E36Q35783949-1C13B571-ABCC-45BD-971A-FE587A365EF4Q36502066-3CC42848-2ED3-4DAC-9373-75B15B77DBFBQ36799486-3BF2231A-34DA-4B54-AB28-1BDBAEE0DA2FQ36900196-9009AA3C-BFB9-49D4-A357-BAFD68D1A069Q37149657-03AAA59D-F703-472F-B0DD-A372A8416151Q37465366-D64F0CFD-8876-4415-8B61-68CD0C20BC3AQ38336510-3AD137F9-044B-4E33-917C-5E0E8F252A3BQ38588078-0D2A9A5C-BBEC-493A-A055-88D4929DE452Q38739234-7CF4CCF7-D0E4-4456-BBEB-71E70732BF81Q38763774-E0D15240-BDCB-4236-AF06-0848312FED3AQ38805764-5AC6F125-BBD3-4991-9543-C20718F6B142Q39062084-597BB06D-D78F-44DF-84D5-6779E896348BQ39140524-AA2CA390-34A1-4DD2-97F9-7294F7D816F0Q41388809-D3633622-427D-4C2B-8083-1C62BF622C85Q41712554-666A727B-BA94-484F-9162-6D538A9139DAQ44339679-DEFA2985-A1D6-44A3-8A03-A74858EF65DDQ46120259-F514FCD2-3A5B-4933-AFCC-2A711B49638CQ47112634-EF65A106-40B1-4DF6-A0D5-7ACE988DA33FQ47272050-DA026A00-2B4D-476E-B02E-22A160C91C11Q47895675-401E0971-ECFD-4166-92A9-453FDDF1611FQ49885231-4D7AB187-6A86-48E5-A14F-19FF986F5690Q52730229-D36A386D-C9C0-4344-805C-E926FFBACE00Q53914539-8BC16D99-718A-4E22-8D47-77B458D8BCDCQ55515148-530FCA44-7023-4B25-BA4F-732AB4866D63Q58552833-B1E5F799-CFD0-4021-91DD-732553AD3F2AQ58700636-508F71F6-95E8-451E-9826-4D30E894FAB2
P2860
Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Noninvasive biomarkers in non- ...... s and a glimpse of the future.
@ast
Noninvasive biomarkers in non- ...... s and a glimpse of the future.
@en
type
label
Noninvasive biomarkers in non- ...... s and a glimpse of the future.
@ast
Noninvasive biomarkers in non- ...... s and a glimpse of the future.
@en
prefLabel
Noninvasive biomarkers in non- ...... s and a glimpse of the future.
@ast
Noninvasive biomarkers in non- ...... s and a glimpse of the future.
@en
P2860
P1476
Noninvasive biomarkers in non- ...... s and a glimpse of the future.
@en
P2860
P304
10851-10863
P356
10.3748/WJG.V20.I31.10851
P407
P577
2014-08-01T00:00:00Z